Status:
TERMINATED
Lupus Education Alliance Program
Lead Sponsor:
Tulane University
Collaborating Sponsors:
University of Alabama at Birmingham
Ochsner Health System
Conditions:
Systemic Lupus Erythematosus
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
Detailed Description
Randomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).
Eligibility Criteria
Inclusion
- 18 years or older, ability to understand and speak English, diagnosis of SLE
Exclusion
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2025
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT05243875
Start Date
November 1 2023
End Date
June 15 2025
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane University
New Orleans, Louisiana, United States, 70112